CYTK
Cytokinetics IncCompany with tickers: CYTK
Market Cap
$10.04B
Shares Outstanding
124,432,565
CIK
1061983
CUSIP
23282W605
13F Activity (30d)
7 filings
5 filers
Website
Visit website
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
11
Net buyers
-8
Net shares bought
-0.14%
Net buy value
-$12,844,863
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-23 | Malik Fady Ibraham |
Director | Convert | 3,500 |
| 2026-06-23 | Malik Fady Ibraham |
Director | Sell | 3,500 |
| 2026-06-23 | Malik Fady Ibraham |
Director | Convert | 3,500 |
| 2026-06-15 | Blum Robert I |
Director, President & CEO | Sell | 7,500 |
| 2026-06-09 | Malik Fady Ibraham |
Director | Sell | 3,500 |
| 2026-06-09 | Malik Fady Ibraham |
Director | Convert | 3,500 |
| 2026-06-09 | Malik Fady Ibraham |
Director | Convert | 3,500 |
| 2026-06-01 | Callos Andrew |
EVP, Chief Commercial Officer | Sell | 15,000 |
| 2026-06-01 | Kaye Edward M. MD |
Director | Sell | 2,933 |
| 2026-06-01 | PARSHALL B LYNNE |
Director | Sell | 5,000 |
| 2026-06-01 | Callos Andrew |
EVP, Chief Commercial Officer | Convert | 15,000 |
| 2026-06-01 | Callos Andrew |
EVP, Chief Commercial Officer | Convert | 15,000 |
| 2026-05-27 | Harrington Robert Arthur |
Director | Award | 2,851 |
| 2026-05-27 | PARSHALL B LYNNE |
Director | Award | 4,301 |
| 2026-05-27 | WIERENGA WENDELL |
Director | Award | 4,301 |
| 2026-05-27 | PARSHALL B LYNNE |
Director | Award | 2,851 |
| 2026-05-27 | Blum Robert I |
Director, President & CEO | Sell | 7,500 |
| 2026-05-27 | Bhanji Muna |
Director | Award | 4,301 |
| 2026-05-27 | Daly James M |
Director | Award | 2,851 |
| 2026-05-27 | HENDERSON JOHN T |
Director | Award | 4,301 |
| 2026-05-27 | Kaye Edward M. MD |
Director | Award | 2,851 |
| 2026-05-27 | WIERENGA WENDELL |
Director | Award | 2,851 |
| 2026-05-27 | Kaye Edward M. MD |
Director | Award | 4,301 |
| 2026-05-27 | Wysenski Nancy |
Director | Award | 2,851 |
| 2026-05-27 | Bhanji Muna |
Director | Award | 2,851 |
| 2026-05-27 | HENDERSON JOHN T |
Director | Award | 2,851 |
| 2026-05-27 | Daly James M |
Director | Award | 4,301 |
| 2026-05-27 | Landry Robert E |
Director | Award | 4,301 |
| 2026-05-27 | Harrington Robert Arthur |
Director | Award | 4,301 |
| 2026-05-27 | Wysenski Nancy |
Director | Award | 4,301 |
| 2026-05-27 | Landry Robert E |
Director | Award | 2,851 |
| 2026-05-19 | Malik Fady Ibraham |
Director | Convert | 3,500 |
| 2026-05-19 | Malik Fady Ibraham |
Director | Sell | 3,500 |
| 2026-05-19 | Malik Fady Ibraham |
Director | Convert | 3,500 |
| 2026-05-14 | Blum Robert I |
Director, President & CEO | Sell | 7,500 |
| 2026-05-05 | HENDERSON JOHN T |
Director | Convert | 20,000 |
| 2026-05-05 | WIERENGA WENDELL |
Director | Convert | 4,032 |
| 2026-05-05 | WIERENGA WENDELL |
Director | Sell | 4,032 |
| 2026-05-05 | Callos Andrew |
EVP, Chief Commercial Officer | Sell | 11,333 |
| 2026-05-05 | Callos Andrew |
EVP, Chief Commercial Officer | Convert | 11,333 |
| 2026-05-05 | Callos Andrew |
EVP, Chief Commercial Officer | Convert | 11,333 |
| 2026-05-05 | WIERENGA WENDELL |
Director | Convert | 4,032 |
| 2026-05-05 | HENDERSON JOHN T |
Director | Sell | 20,000 |
| 2026-05-05 | Malik Fady Ibraham |
Director | Convert | 3,500 |
| 2026-05-05 | Lee Sung |
Director | Sell | 23,906 |
| 2026-05-05 | Malik Fady Ibraham |
Director | Sell | 3,500 |
| 2026-05-05 | Malik Fady Ibraham |
Director | Convert | 3,500 |
| 2026-05-05 | HENDERSON JOHN T |
Director | Convert | 20,000 |
| 2026-05-01 | Callos Andrew |
EVP, Chief Commercial Officer | Sell | 15,857 |
| 2026-05-01 | Callos Andrew |
EVP, Chief Commercial Officer | Convert | 15,857 |
Showing 1–50 of 1,633 transactions